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Abstract
Objective: The aim of this study was to investigate the effects of robotic 
rehabilitation (RR) on spasticity and motor functions of children with varying types 
and functional levels of cerebral palsy (CP).
Materials and Methods: A total of 28 children were evaluated aged 6-16 years, 
with level 2-4 CP according to the Gross Motor Function Classification System 
(GMFCS) who were planned to undergo 30 sessions of RR. Motor functions were 
evaluated before and after RR using the Gross Motor Function scale-66 (GMFS-66) 
B, C, D and E dimensions, gastrosoleus spasticity with the Modified Ashworth scale 
(MAS) and a target was defined for each patient with a Goal Attainment scale 
(GAS). Following the RR treatment, the efficacy was evaluated by grouping the 
patients according to the GMFCS level and the type of CP. 
Results: 11% of the patients were at level 2, 36% were at level 3, and 54% were 
at level 4.61% of them were identified as bilateral spastic, 21% unilateral spastic 
and 14% mixed type. The patients comprised 50% male and 50% female children 
with a mean age of 10.8±2.7 years. Mean participation in the RR program was 
23±9.6 sessions. A statistically significant improvement was determined in the D 
dimension of the GMFS in the children at level 2 and 3 of GMFCS (p<0.05), and 
there were no differences in respect of the MAS and GAS (p>0.05). No differences 
were determined between the type of CP groups in respect of GMFS, MAS and GAS. 
Conclusion: It was concluded that the application of RR was of benefit for the 
children with CP at the level 2 and 3 of GMFCS in respect of the development of 
standing activities. 
Amaç: Bu çalışmanın amacı, farklı fonksiyon düzey ve tipteki serebral palsili (SP) 
çocuklarda robotik rehabilitasyonun (RR), spastisite ve motor fonksiyonlara etkisini 
araştırmaktır. 
Gereç ve Yöntemler: Otuz seans RR planlanan, 6-16 yaş arasında, Kaba Motor 
Fonksiyon Sınıflama Sistemi (KMFSS) 2-4 düzeyinde olan 28 SP’li çocuğun sonuçları 
değerlendirildi. RR öncesi ve sonrasında fonksiyon Kaba Motor Fonksiyon ölçüm-66 
Effects of Robotic Rehabilitation on 
Motor Functions in Children with 
Cerebral Palsy
doi:10.4274/meandros.06078
Our study was presented as an absract at INEREM 
International Neurology and Rehabilitation Meeting 
04-06th June 2015, Wyndham Grand Hotel, İstanbul.
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Introduction
One of the targets in cerebral palsy (CP) 
rehabilitation is to provide mobility according to the 
expectations of the patient, the clinical examination 
findings and patient characteristics. Therefore, in 
rehabilitation programs there has been increasing 
widespread use of robotic technology that has been 
developed with the aim of facilitating or correcting 
the gait, thereby providing functional walking (1-3). 
Robot-assisted gait training is based on the principles 
of sensorimotor learning. Through the intensive and 
repeated visual and auditory stimuli given in the 
different phases of walking, it is intended to regain 
functional ambulation (4). 
There is not yet considered to be sufficient 
information to be able to form recommendations 
for robot-assisted walking in CP childen (5,6). Some 
studies have reported that robot-assisted walking has 
provided an increase in gross motor skills, walking 
speed and resistance (4,7-13), and an increase in 
participation and performance of daily living activities 
(9,14). However, it has been claimed that there is a 
need for stronger evidence of the role and efficacy of 
robot-assisted walking in the clinical treatment of CP 
children (10,15). 
There have been seen to be conflicting results 
related to the efficacy of robot-assisted walking 
training in CP children at different motor functional 
levels (7,13,16). van Hedel et al. (7) reported 
developments in mobility and gross motor function in 
children of level 3 and 4 according to the Gross Motor 
Function Classification System (GMFCS), while there 
was no development in level 2 children. Borggraefe 
et al. (13) determined a greater development in gross 
motor function in level 1 and 2 children compared to 
those of level 3 and 4. In a study by Willoughby et 
al. (16) it was reported that gait training on a walking 
band was of more benefit to children who were more 
severely affected functionally. However, to the best of 
our knowledge, there has been no previous study that 
has investigated the efficacy of robotic rehabilitation 
(RR) in different types of CP. Therefore, the aim of this 
study was to evaluate the response to RR in terms of 
motor function development in children with different 
types and motor functional level of CP, who were 
planned to undergo robot-assisted walking training. 
Materials and Methods
The data of children with CP, aged 6-16 years, who 
applied to the outpatient clinic of physical therapy 
(PT) and rehabilitation department and who were 
eligible for RR were analysed retrospectively. The 
Ethics Committee of the University of Health Sciences, 
Antalya Training and Research Hospital approved 
the study (approvel number: 2015-029). A total of 
30 sessions of RR was scheduled for the children 
with CP who were at GMFCS level 2-4, had received 
no botulinum toxin injections or surgical treatment 
within the previous 3 months, had sufficient mental 
function and did not have treatment-resistant 
epilepsy, any sight or hearing problem, contracture 
of the lower extremity, fracture or joint instability, 
hip dislocation or any circulation problems. Motor 
functions were evaluated using the Gross Motor 
Function scale (GMFS), and gastrosoleus spasticity 
with the Modified Ashworth scale (MAS). Taking the 
GMFS results into consideration and using a Goal 
Attainment scale (GAS), a target was defined for each 
patient. All evaluations were performed twice, before 
and after RR, in all patients.
The GMFCS is a standardised method that classifies 
gross motor function in CP Children into 5 levels: level 
1, walking without restriction; level 2, walking with 
restriction; level 3, walking with a hand-held assistive 
device; level 4, limited independent movement and 
can use a motorised mobility device; level 5, moved 
by wheelchair (17).
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(KMFÖ-66) B, C, D, E boyutları ile, gastrosoleus spastisitesi Modifiye Ashwort skalası (MAS) testi ile değerlendirildi ve her hasta için 
Hedefe Ulaşma skalası (HUS) ile hedef belirlendi. RR tedavisi sonrası, KMFSS düzeyi ve SP tipine göre gruplama yapılarak etkinlik 
değerlendirildi. 
Bulgular: Çocukların %11’i evre 2, %36’sı evre 3, %54’ü evre 4’de, %61’i bilateral spastik, %21’i unilateral spastik, %14’ü miks 
tipteydi. Hastaların %50’si erkek ve ortalama yaş 10,8±2,7 yıldı. RR programına ortalama katılım 23±9,6 seanstı. RR sonrası KMFSS 
evre 2 ve 3 çocuklarda KMFÖ, D boyutunda gelişme olduğu saptandı (p<0,05), MAS ve HUS yönünden fark yoktu (p>0,05). SP tipine 
göre gruplar arasında KMFÖ, MAS ve HUS yönünden anlamlı fark saptanmadı. 
Sonuç: RR uygulamasının, KMFSS 2 ve 3 evredeki çocuklarda ayakta durma aktivitelerinin gelişmesinde yararlı olduğu kararına 
varıldı. 
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Classification according to the type of CP was 
made according to the Surveillance of Cerebral Palsy 
in Europe (SCPE) and was defined as bilateral spastic, 
unilateral spastic and mixed (18). Although there is no 
mixed type in the SCPE classification, the presence of 
spasticity and ataxia together was defined as mixed 
type.
To measure the gross motor functions, the 
standard points of the GMFS were calculated. This 
scale comprises 66 items in 5 dimensions in terms of 
A, lying and turning (4 items); B, sitting (15 items); C, 
crawling-kneeling (10 items); D, standing (13 items); 
and E, walking, running, jumping (24 items) (19). 
In the study, lying and turning functions were not 
evaluated, so dimensions B, C, D and E were calculated 
for evaluation. 
The MAS was applied to classify gastrosoleus 
spasticity. Resistance to passive motion was measured 
on the following 5-point scale: 0) no increased 
resistance; 1) slightly increased reisitance; 2) clear 
resistance throughout most of the range of motion; 
3) strong resistance, movement is difficult; 4) rigit 
flexion or extension (20). 
GAS is an individualized, goal-oriented 
measurement tool rated by the physician and patient 
to track functional improvement; scores ranged 
from –3 (worse than start) to +2 (much more than 
expected, improvements clearly exceeded the defined 
therapeutic goal) based on a 6-point scale. Active 
and/or passive goals were set for each child by the 
patient and the investigator at screening based on the 
GMFS results and the performance of the child (21) 
(Table 1). 
The RR application as performed 5 days per 
week, 40 min per session, 30 sessions in total with 
the RoboGait (BAMA Technology, Turkey) device, 
which is a robot-aided gait training system that helps 
the patients improve their walking abilities. The 
system was composed of a suspension system which 
could move the patient up and down, backwards 
and forwards, a screen providing feedback on the 
interaction of the patient and formed as a robotic 
walking orthosis providing active movements of the 
legs and the low-speed walking band on which the 
patient is walking. The robotic orthosis has motors 
providing active movement in the hip and knee joints 
and power sensors measuring the torque on the 
joints. 
Statistical Analysis
All statistical analyses were applied using SPSS 
version 18.0 software. The differences in the GMFS, 
MAS and GAS data before and after treatment were 
calculated and values recorded as median, minimum 
and maximum. In the comparison of the gender 
distribution in the groups, the chi-square test was 
used, and for intra-group evaluations, the Wilcoxon 
test. The differences before and after RR were 
compared between groups using the Kruskal-Wallis 
test. For the comparison of significant data between 
groups, the Mann-Whitney U test was applied. A value 
of p<0.05 was accepted as statistically significant. 
Results 
The study included 28 children with CP; 14 males 
and 14 females. The GMFCS levels were 2 in 11%, 3 
in 36% and 4 in 54%. All the GMFCS level 2 children 
were unilateral spastic, those at level 3 were 20% 
unilateral spastic, 70% bilateral spastic and 10% mixed 
type. Those at level 4 were 7% unilateral spastic, 7% 
dyskinetic, 67% bilateral spastic and 20% mixed type. 
The 1 child who was dyskinetic was not included in 
the statistical evaluation.
The age and duration of each session were smilar 
in all patients when they were stratified according to 
the GMFCS or CP type (p>0.05). The number of RR 
sessions in the bilateral spastic group was greater 
than in the mixed group (p=0.031) (Tables 2, 3). 
At baseline, there were no differences between 
the GMFCS groups in respect of GMFS-B and MAS 
(p>0.05). A statistically sinificant difference was 
determined between the groups in respect of 
GMFS-C, (chi-square=11.770, p=0.003), GMFS-D, 
(chi-square=15.332, p<0.001), and GMFS-E (chi-
square=17.138, p<0.001). The points of the level 2 
children were higher than those of the level 3 and 4 
children, and the points of the level 3 children were 
higher than those of level 4 (p<0.05) (Table 2). 
At baseline, there were no differences between the 
CP type groups in respect of GMFS-B, C and E points 
(p>0.05). The GMFS-D points were determined to 
be different between the groups (chi-square=7.805, 
p=0.020). No difference was determined between 
the bilateral spastic and the mixed group in respect of 
the GMFS-D points (p>0.05). The GMFS-D (standing) 
points of the unilateral spastic group were higher than 
those of the bilateral spastic group (p<0.05).
Bilgilisoy Filiz et al. Cerebral Palsy and Robotic Rehabilitation
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In intra-group comparisons according to the GMFCS 
level, of before and after treatment, no significant 
differences were observed in the GMFCS level 2 
children in respect of all the GMFS, MAS and GAS 
(p>0.05). In the GMFCS grade 3 children, no difference 
was determined in the GMFS-C points (p>0.05), 
however there were significant improvements in the 
GMFS-B, D and E values (z=-2.214, p=0.027; z=-2.812, 
p=0.005; z=-2.201, p=0.028, respectively) and in 
MAS and GAS (z=-2.530, p=0.011; z=-2.558, p=0.011, 
respectively). In the GMFCS level 4 children, GMFS-D 
and E dimensions (z=-2.032, p=0.042; z=-2.032, 
p=0.042, respectively) and MAS and GAS (z=-2.460, 
p=0.014; z=-2.714, p=0.007, respectively) improved 
significantly when compared to baseline values, but 
no significant difference was observed in values of 
GMFS-B and C dimensions (p<0.05) (Table 2).
When intra-group comparisons were done according 
to the CP type, no significant change was observed 
after treatment in the bilateral spastic children in 
respect of the GMFS-B and C points (p>0.05), however 
there were significant improvements in D and E points 
(z=-2.821, p=0.005; z=-2.403, p=0.016, respectively), 
and MAS and GAS measurements (z=-3.217, p=0.001; 
z=-3.100, p=0.002, respectively). No significant change 
was observed in the unilateral spastic children in 
Table 1. The targets of the patients according to the Goal Attainment scale
Patient Target
1 A.M.Y. To sit on the mat for at least 3 secs with the arms free and independent
2 B.E.Ş. To sit on a chair for at least 10 secs with the arms free and independent
3 B.K. To stand for at least 20 secs with the arms free and independent
4 C.B. To sit on a chair for at least 10 secs with the arms free and independent
5 D.D. To stand supported by 1 hand
6 E.D. To walk 10 steps forward and turn 180°
7 E.C.İ. In a standing position supported by 1 hand, to raise 1 foot from the floor and hold this position for at least 3 secs
8 E.M.Ç. In a full kneeeling position, to advance 4 steps with the arms free
9 E.A. To come to a half-kneeling position from a full kneeling position and hold this position for at least 10 secs
10 E.B. To sit on the mat for at least 3 secs with the arms free and independent
11 E.H.U. To stand for at least 20 secs with the arms free and independent
12 E.K. To extend one arm forward while in a crawling position
13 E.K. To come to a half-kneeling position from a full kneeling position and hold this position for at least 10 secs
14 F.A.K. To come to a half-kneeling position from a full kneeling position and hold this position for at least 10 secs
15 H.İ. To sit on the mat for at least 3 secs with the arms free and independent
16 H.G. To stand independently and raising 1 leg, hold this position for at least 10 secs
17 H.C.U. To step over an obstruction at ankle level
18 M.K. To stand for at least 20 secs with the arms free and independent
19 M.C.K. To stand for at least 20 secs with the arms free and independent
20 R.Ö. To stand independently and raising 1 leg, hold this position for at least 10 secs
21 S.A. In a crawling position, to make reciprocal forward crawling 
22 S.G.E. To walk 10 steps forward
23 S.E. To walk 10 steps forward and turn 180°
24 S.K. To walk 10 steps forward 
25 Ş.K. To sit on the mat for at least 3 secs with the arms free and independent
26 T.T. To sit on the mat for at least 3 secs with the arms free and independent
27 T.Ş. In a crawling position, to make reciprocal forward crawling
28 V.Y. To step over an obstruction at ankle level
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respect of the GMFS points, MAS and GAS (p>0.05). 
In the mixed type spastic children, no difference was 
determined in the GMFS-B, C and E points and MAS 
(p>0.05). A significant increase was determined in 
the GMFS-D points and in GAS (z=-2.207, p=0.027; z=-
2.121, p=0.034, respectively) (Table 3).
When inter-group comparisons were performed 
after the RR, no difference was determined between 
the GMFCS groups in respect of GAS, MAS and 
GMFS-B, C and E points (p>0.05), however, GMFS-D 
values were significantly different (chi-square=16.564, 
p<0.001). The increase in the GMFS-D points in the 
level 2 and level 3 children was greater than the 
increase in those at grade 4 (z=-2.214, p=0.027; z=-
3.915, p<0.001, respectively) (Table 2). No statistically 
significant difference was determined between the CP 
type groups in respect of all the GMFS points, MAS 
and GAS (p>0.05) (Table 3). 
Discussion
The aim of this study was to evaluate the response 
to RR in respect of motor function development in 
children with CP of different types and with different 
levels of motor function. At the end of treatment, 
while no change was observed in the GMFS points of 
the level 2 children, an increase was determined in 
the GMFS-B, D and E points of the level 3 children, and 
in the GMFS-D and E points of the level 4 children. No 
change was seen in MAS and GAS in level 2 children, 
whereas a decrease in MAS and an increase in GAS 
were seen in level 3 and level 4 children. In the group 
comparisons, the increase in the GMFS-D points of 
the level 2 and 3 children was greater than in the 
grade 4 children. 
There have been conflicting reports related to the 
efficacy of RR applied to children with CP at different 
gross motor function levels (7,13). van Hedel et al. 
(7) applied a mean of 20 RR sessions in addition to a 
regular physiotherapy program in a group of children 
with CP aged 4-20 years, comprising 15% level 2, 23% 
level 3, and 29% level 4. They reported that while there 
was no development in level 2 children, significant 
improvements were observed in GMFS-D and E points 
of level 3 and 4 children, without significant differences 
between the groups. Borggraefe et al. (13) applied 12 
sessions of RR and determined a greater development 
in GMFS-D in level 1 and 2 children compared to those 
of level 3 and 4. In a study by Willoughby et al. (16), it 
Table 2. Improvement in spasticity, Gross Motor Function Measure, and Goal Attainment scale in different levels of 
Gross Motor Funtion Classification System










Age, year 12 (10-13) 11 (8-14) 11 (6-16)
Number of sessions 26 (26-31) 31.5 (25-32) 28 (20-32)
Duration per session, min 37 (33-40) 39.5 (33-54) 34 (26-44)
BT AT D BT AT D BT AT D
MAS 2 (1-2) 1 (1) -1 (-1-0) 2 (1-3) 1 (1-3)§ -1 (-1-0) 2 (1-3) 1 (1-3)§ 0 (-1-0)













































































*Kruskal Wallis, †Mann-Whitney U, level 2-4, ‡Mann-Whitney U, level 3-4, §Wilcoxon, p<0.05
BT: Before treatment, AT: After treatment, D: Difference, MAS: Modifiye Ashwort scale, GAS: Goal Attainment scale, GMFS: Gross Motor Function scale, 
B: Sitting dimension, C: Crawling- kneeling dimension, D: Standing dimension, E: Walking, running, jumping dimension, min: Minimum, max: Maximum 
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was reported that the children with more functional 
disability were more likely to benefit from RR.
In studies that have compared RR with conventional 
PT, different results have been reported in respect of 
efficacy (4,10,11,22,23). In a study which compared 
20 sessions of RR and PT in bilateral spastic, level 2 
children aged 8-10 years, improvement was recorded 
in the RR group in GMFS-D and E points (4). Another 
study found no difference between a PT group and an 
RR group in kinematics and step length, step width and 
walking speed measurement in level 2-3 CP children 
aged 6-13 years with spastic diplegia (10). Level 2-4, 
bilateral spastic CP children aged 4-12 years were 
compared as a hospitalised group applied with 20x45-
min sessions of PT and an outpatient group applied 
with 12x60-min sessions of RR, and no difference 
was determined between the groups, with a similar 
increase in walking speed and GMFS-D points in both 
groups (11). In level 1-3, bilateral spastic CP children 
aged 4-17 years, treatment was applied for 4-10 
weeks at a frequency of 4-10 sessions per week and 
no difference was determined between the RR, PT 
and PT+RR protocols. Similar results were determined 
to have been obtained from the robotic application 
and the physiotherapy, and it was concluded that a 
single application was more beneficial than combined 
applications, with reported improvements in GMFS-D 
and E points in all groups (22). In a study by Romei et 
al. (23), 20 sessions of RR and PT were compared with 
RR alone in bilateral spastic CP children, and it was 
reported that both groups improved and there was 
no difference between the groups in respect of the 
improvement in gross motor function. 
van Hedel et al. (7) determined a strong relationship 
between the GMFS-E dimension and the total number 
of treatment sessions in level 2 CP children. In that 
study, although not significant, the total number of RR 
sessions was higher, and the duration of the sessions 
was longer in grade 2 and 3 children. Despite the lack 
of studies directly comparing RR treatment doses, 
that children who were more affected in respect of 
motor function were likely to benefit more from the 
application of a greater total number of sessions 
and longer session duration (7). Researchers have 
emphasised that more severely impaired children 
benefit more from a greater number of sessions, and 
longer walking distance and duration of the sessions, 
while lesser affected children benefit from high 











Age, year 12 (6-16) 10 (8-13) 11 (7-16)
Number of sessions 30 (20-32)† 26 (21-32) 22.5 (21-27)*†
Duration per session, min 37 (29-54)  36.5 (32-44) 32 (26-39)

















































































































*Kruskal-Wallis; †Mann-Whitney U, ‡Wilcoxon, p<0.05
BT: Before treatment, AT: After treatment, D: Difference, MAS: Modifiye Ashwort scale, GAS: Goal Attainment scale, GMFS: Gross Motor Function scale, 
B: Sitting dimension, C: Crawling- kneeling dimension, D: Standing dimension, E: Walking, running, jumping dimension, min: Minimum, max: Maximum
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intensity programs of shorter duration (24,25). 
In the current study, while no change was 
determined in GMFS points, MAS and GAS in unilateral 
spastic children, an increase was determined in 
GMFS-D and E and an improvement in MAS and GAS 
measurements in bilateral spastic children. In the 
mixed type children, an increase was determined 
in GMFS-D points and GAS. No difference was 
determined in the GMFS, MAS and GAS between the 
CP types. As there is no previous study in literature 
that has evaluated the efficacy of RR in different CP 
types, no comparison could be made. Although there 
was no difference between the CP types in respect of 
MAS, the MAS median value was found to be higher 
in the bilateral spastic and mixed type groups. The 
improvement in motor function in the bilateral spastic 
and mixed type groups can be considered to be due 
to a reduction in partial spasticity, associated with the 
negative effect of spasticity on gross motor function 
(26). 
It has been emphasised that for there to be benefits 
of robotic walking training in respect of improvements 
in walking speed, resistance and gross motor functions 
in children with CP, the program should be applied at 
a frequency of 4 days per week with sessions of at 
least 30 mins (30) and it has been stated that strong 
evidence is required to determine the role of robot-
assisted walking in CP children (10,15). 
The primary limitation of the current study was 
the low sample size of different motor function grades 
and different CP types, and that there was no control 
group. Second is that the anthropometric details of the 
children and energy consumption were not recorded 
as it has been previously reported that anthropometric 
differences affect gait kinetics and motor behaviour 
(3). It has been emphasised that a reduction in energy 
consumption is related to a reduction in contractions 
of spastic muscles and a more effective gait pattern 
(3). A third limitation was that details could not be 
obtained of the reliable application of the RR as it was 
implemented at a different centre.
Conclusion
In conclusion, although several methodological 
limitations prevent definite conclusions, a number of 
potential clinical implications emerge from this study. 
Our results showed that RR application is beneficial 
for improving standing activities in bilateral spastic 
children with CP at GMFCS level 2 and 3. Further 
prospective studies are needed to confirm these 
results in larger groups of patients to improve the 
evidence-based application of RR.
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